These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 10575321)

  • 1. Plasma insulin-like growth factor-I and serum IGF-binding protein 3 can be associated with the progression of breast cancer, and predict the risk of recurrence and the probability of survival in African-American and Hispanic women.
    Vadgama JV; Wu Y; Datta G; Khan H; Chillar R
    Oncology; 1999 Nov; 57(4):330-40. PubMed ID: 10575321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic factors related to racial variation in plasma levels of insulin-like growth factor-1: implications for premenopausal breast cancer risk.
    Jernström H; Chu W; Vesprini D; Tao Y; Majeed N; Deal C; Pollak M; Narod SA
    Mol Genet Metab; 2001 Feb; 72(2):144-54. PubMed ID: 11161840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum insulin-like growth factor (IGF)-I and IGF binding protein-3 in relation to terminal duct lobular unit involution of the normal breast in Caucasian and African American women: The Susan G. Komen Tissue Bank.
    Oh H; Pfeiffer RM; Falk RT; Horne HN; Xiang J; Pollak M; Brinton LA; Storniolo AMV; Sherman ME; Gierach GL; Figueroa JD
    Int J Cancer; 2018 Aug; 143(3):496-507. PubMed ID: 29473153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic, anthropometric, and lifestyle factors associated with IGF-1 and IGFBP-3 levels in Hispanic and non-Hispanic white women.
    Slattery ML; Baumgartner KB; Byers T; Guiliano A; Sweeney C; Herrick J; Curtin K; Murtaugh M; Wolff R
    Cancer Causes Control; 2005 Dec; 16(10):1147-57. PubMed ID: 16215864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A polymorphic locus in the promoter region of the IGFBP3 gene is related to mammographic breast density.
    Lai JH; Vesprini D; Zhang W; Yaffe MJ; Pollak M; Narod SA
    Cancer Epidemiol Biomarkers Prev; 2004 Apr; 13(4):573-82. PubMed ID: 15066922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin-like growth factor-I (IGF-I) and IGF-binding proteins blood serum levels in women with early- and late-stage breast cancer: mutual relationship and possible correlations with patients' hormonal status.
    Favoni RE; de Cupis A; Perrotta A; Sforzini S; Amoroso D; Pensa F; Miglietta L
    J Cancer Res Clin Oncol; 1995; 121(11):674-82. PubMed ID: 7593132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The insulin-like growth factor family and breast cancer prognosis: A prospective cohort study among postmenopausal women in Denmark.
    Kalledsøe L; Dragsted LO; Hansen L; Kyrø C; Grønbæk H; Tjønneland A; Olsen A
    Growth Horm IGF Res; 2019 Feb; 44():33-42. PubMed ID: 30622040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor biologic factors and breast cancer prognosis among white, Hispanic, and black women in the United States.
    Elledge RM; Clark GM; Chamness GC; Osborne CK
    J Natl Cancer Inst; 1994 May; 86(9):705-12. PubMed ID: 7908990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum insulin-like growth factor (IGF)-1 and IGF binding protein-3 in relation to breast cancer among Hispanic and white, non-Hispanic women in the US Southwest.
    Rollison DE; Giuliano AR; Risendal BC; Sweeney C; Boulware D; Laronga C; Baumgartner KB; Byers T; Slattery ML
    Breast Cancer Res Treat; 2010 Jun; 121(3):661-9. PubMed ID: 19888649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations of insulin-like growth factor and insulin-like growth factor binding protein-3 with mortality in women with breast cancer.
    Duggan C; Wang CY; Neuhouser ML; Xiao L; Smith AW; Reding KW; Baumgartner RN; Baumgartner KB; Bernstein L; Ballard-Barbash R; McTiernan A
    Int J Cancer; 2013 Mar; 132(5):1191-200. PubMed ID: 22847383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum insulin-like growth factor-I and insulin-like growth factor binding protein-3 following chemotherapy for advanced breast cancer.
    Holdaway IM; Mason BH; Lethaby AE; Singh V; Harvey VJ; Thompson PI; Evans BD
    ANZ J Surg; 2003 Nov; 73(11):905-8. PubMed ID: 14616567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum IGF-1, IGFBP-3 levels and circulating tumor cells (CTCs) in early breast cancer patients.
    Papadakis GZ; Mavroudis D; Georgoulias V; Souglakos J; Alegakis AK; Samonis G; Bagci U; Makrigiannakis A; Zoras O
    Growth Horm IGF Res; 2017 Apr; 33():28-34. PubMed ID: 28258988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of insulin-like growth factor 1 and insulin-like growth factor binding protein 3 blood levels in breast cancer.
    Hartog H; Boezen HM; de Jong MM; Schaapveld M; Wesseling J; van der Graaf WT
    Breast; 2013 Dec; 22(6):1155-60. PubMed ID: 23968866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies.
    ; Key TJ; Appleby PN; Reeves GK; Roddam AW
    Lancet Oncol; 2010 Jun; 11(6):530-42. PubMed ID: 20472501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of plasma HER-2/neu in African American and Hispanic women with breast cancer.
    Wu Y; Khan H; Chillar R; Vadgama JV
    Int J Oncol; 1999 Jun; 14(6):1021-37. PubMed ID: 10339653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating concentrations of insulin-like growth factor-I, insulin-like growth factor-binding protein-3, genetic polymorphisms and mammographic density in premenopausal Mexican women: results from the ESMaestras cohort.
    Rinaldi S; Biessy C; Hernandez M; Lesueur F; dos-Santos-Silva I; Rice MS; Lajous M; Lopez-Ridaura R; Torres-Mejía G; Romieu I
    Int J Cancer; 2014 Mar; 134(6):1436-44. PubMed ID: 24037648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic variation in IGF1, IGF-1R, IGFALS, and IGFBP3 in breast cancer survival among Chinese women: a report from the Shanghai Breast Cancer Study.
    Deming SL; Ren Z; Wen W; Shu XO; Cai Q; Gao YT; Zheng W
    Breast Cancer Res Treat; 2007 Sep; 104(3):309-19. PubMed ID: 17063263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Racial differences in the association between body mass index and serum IGF1, IGF2, and IGFBP3.
    Fowke JH; Matthews CE; Yu H; Cai Q; Cohen S; Buchowski MS; Zheng W; Blot WJ
    Endocr Relat Cancer; 2010 Mar; 17(1):51-60. PubMed ID: 19786462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of droloxifene on plasma levels of insulin-like growth factor (IGF)-I, Pro-IGF-IIE, insulin-like growth factor binding protein (IGFBP)-1 and IGFBP-3 in breast cancer patients.
    Helle SI; Anker GB; Tally M; Hall K; Lønning PE
    J Steroid Biochem Mol Biol; 1996 Feb; 57(3-4):167-71. PubMed ID: 8645625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum insulin-like growth factors I and II, insulin-like growth factor binding protein-3 and risk of breast cancer in the Japan Collaborative Cohort study.
    Sakauchi F; Nojima M; Mori M; Wakai K; Suzuki S; Tamakoshi A; Ito Y; Watanabe Y; Inaba Y; Tajima K; Nakachi K
    Asian Pac J Cancer Prev; 2009 Dec; 10 Suppl():51-5. PubMed ID: 20553082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.